Functional chromatin regulation region and target gene identification method and system

Through functional chromatin regulatory regions and target gene identification methods, the gaped-kmer SVM model and linear regression model are used to solve the problem of how genomic regulatory elements regulate gene expression, reduce sequencing costs, and realize the activity of genomic regulatory elements and target genes. The systematic identification of the disease provides a theoretical basis for the study of the genetic mechanism of complex diseases.

CN119091963APending Publication Date: 2024-12-06XI AN JIAOTONG UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411243218.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art cannot effectively detect how genomic regulatory elements regulate gene expression, and the high-cost ATAC-seq or ChIP-seq sequencing limits the application of research, making it difficult to explore the relationship between regulatory element function and target genes in actual research.

Method used

Functional chromatin regulatory region and target gene identification method were used to predict activity scores for upstream and downstream sequences of SNP allele types using the trained gapped-kmer SVM model, and the correlation between gene and PRE activity in promoter region was calculated through linear regression model. , and statistically significant regulatory elements-target gene regulation results were screened out, reducing the sequencing cost requirement.

Benefits of technology

Without the need for high-cost sequencing of large sample populations, it can systematically identify the activity of genome regulatory elements and target genes, reduce research costs and time, and provide a theoretical basis for the genome regulation mechanism of complex human diseases. It is suitable for genetic mechanism research and drugs in the field of biomedical science. Development.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119091963A_ABST
    Figure CN119091963A_ABST
Patent Text Reader

Abstract

The invention discloses a functional chromatin regulation region and target gene identification method and system, and belongs to the technical field of biology. The method comprises the following steps: screening a regulatory element region on a genome; predicting activity scores of the upstream and downstream 9bp sequences of the two allelotypes of all the SNPs in all the regulatory element regions by using the trained gapped-kmer SVM model; for each individual of the eQTL population, according to the genotype information of each SNP and the activity score of each allele type, calculating the activities of all PREs; for each gene, calculating correlation between the gene and all PRE activities in upstream and downstream preset ranges of a promoter of the gene by using a linear regression model, and calculating an effect value beta of linear regression so as to obtain a significance P value; and performing multiple inspection correction according to the total detection number of the significance P value, and screening out a statistical significant result as a final regulation and control element-target gene regulation and control result. The method can be used for systematically exploring the functions of the genome regulatory element and the target gene influenced by the genome regulatory element.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention provides a method and system for identifying a functional chromatin regulatory region and a target gene, and belongs to the field of biotechnology. Background Art

[0002] In the genetic regulation of complex diseases, a large number of regulatory elements in the non-coding regions of the genome play an important role, and their activation and inhibition can affect the risk of disease. It is currently believed that these regulatory elements mainly affect the occurrence of diseases by regulating the expression of nearby and distal genes, but the specific mechanisms of which genetic factors affect these regulatory elements and how they regulate gene expression are still unclear. A large number of expression quantitative trait loci (eQTL) sites have been identified in dozens of tissues, which can analyze the effects of single nucleotide polymorphisms (SNPs) on gene expression, but eQTL still cannot detect how specific genomic elements regulate target genes.

[0003] To understand how genomic regulatory elements regulate gene expression, the most direct method is to simultaneously perform transcriptome sequencing and chromatin accessibility sequencing (Assay for Transposase-Accessible Chromatin with high-throughput sequencing, ATAC-seq) or chromatin immunoprecipitation sequencing (ChIP-seq) of multiple histones / transcription factors in population samples. However, the cost of ATAC-seq or ChIP-seq is much higher than transcriptome sequencing. The sequencing cost in population samples is too high and difficult to apply in actual research, which hinders the study of the relationship between mutation sites, regulatory element functions and gene expression. Summary of the invention

[0004] In order to overcome the shortcomings of the prior art, the present invention provides a method and system for identifying functional chromatin regulatory regions and target genes. The method can be used to systematically explore the functions of genomic regulatory elements and the target genes they affect.

[0005] In order to solve the above technical problems, the technical solution adopted by the present invention is:

[0006] In a first aspect, the present invention provides a method for identifying a functional chromatin regulatory region and a target gene, comprising:

[0007] Screen the regulatory element regions on the genome; use the trained gapped-kmer SVM model to predict the activity scores of the 9bp sequences upstream and downstream of the two alleles of all SNPs in all regulatory element regions;

[0008] For each individual in the eQTL population, the activities of all PREs were calculated based on the activity score of each allele type according to the genotype information of each SNP;

[0009] For each gene, a linear regression model was used to calculate the association between the gene and all PRE activities within a preset range upstream and downstream of its promoter, and the effect value β of the linear regression was calculated to obtain a significant P value.

[0010] Multiple testing correction was performed based on the total number of significant P-value tests, and statistically significant results were screened out as the final regulatory element-target gene regulation results.

[0011] As a further improvement of the present invention, the screening of regulatory element regions on the genome comprises:

[0012] All ATAC-seq / ChIP-seq peak regions on the genome were used as candidate regulatory element regions, and the following PRE regions were filtered out:

[0013] a) There are base insertion and deletion mutations in the PRE region;

[0014] b) The number of independent SNPs in the region within the PRE is less than 2, and the independence threshold is linkage disequilibrium R2>0.3;

[0015] c) There are two SNPs within the PRE with a distance <10 bp between them.

[0016] As a further improvement of the present invention, the training process of the gapped-kmer SVM model includes:

[0017] The sequences within 100 bp upstream and downstream of the peak point in the ATAC-seq / ChIP-seq peak area were taken as the positive set, and the same number of sequences in the non-peak area of ​​ATAC-seq / ChIP-seq were randomly taken as the negative set;

[0018] The negative set and positive set sequences were used as training sets, and the gapped-kmer SVM model was trained in a 5-fold crossover method to search for the optimal hyperparameters. The model with the highest surface under the precision-recall curve of the validation set was taken as the trained gapped-kmer SVM model.

[0019] As a further improvement of the present invention, the non-peak region sequence is a region with a call peak P value>0.2, and the length, repetition rate, and GC content of the negative set sequence randomly obtained in the negative set are the same as those of the positive set.

[0020] As a further improvement of the present invention, the activity of all PREs is calculated according to the activity score of each allele type, and the calculation method is:

[0021]

[0022] where CAS is the PRE activity, n is the number of SNPs in the PRE region, m is the number of alleles of SNP i, G is the dosage effect of allele j, and S is the score of allele j predicted by the gapped-kmer SVM model.

[0023] As a further improvement of the present invention, the linear regression model is:

[0024] eX]pres810110×CAS+Covariates

[0025] Among them, expression is the expression value of the gene after standardization, CAS is the activity of the PRE, Covariates is the population covariate, and β is the effect value of the PRE on gene expression.

[0026] In a second aspect, the present invention provides a functional chromatin regulatory region and target gene identification system, comprising:

[0027] The activity score prediction module is used to screen the regulatory element regions on the genome; the trained gapped-kmerSVM model is used to predict the activity scores of the 9bp sequences upstream and downstream of the two allele types of all SNPs in all regulatory element regions;

[0028] The activity calculation module is used to calculate the activity of all PREs according to the activity score of each allele type for each individual in the eQTL population based on the genotype information of each SNP;

[0029] The significant P value calculation module is used to calculate the association between each gene and all PRE activities within the preset range of the upstream and downstream of its promoter using a linear regression model, calculate the effect value β of the linear regression, and then obtain the significant P value;

[0030] The result screening module is used to perform multiple test correction according to the total number of detections of significant P values, and screen out statistically significant results as the final regulatory element-target gene regulation results.

[0031] In a third aspect, the present invention provides an electronic device comprising a memory, a processor, and a computer program stored in the memory and executable on the processor, wherein the processor implements the method for identifying functional chromatin regulatory regions and target genes when executing the computer program.

[0032] In a fourth aspect, the present invention provides a computer-readable storage medium, wherein the computer-readable storage medium stores a computer program, and when the computer program is executed by a processor, the method for identifying functional chromatin regulatory regions and target genes is implemented.

[0033] In a fifth aspect, the present invention provides a computer program product, comprising computer instructions, wherein the computer instructions instruct a computer to execute the method for identifying functional chromatin regulatory regions and target genes.

[0034] The beneficial effects of the present invention compared with the prior art are as follows:

[0035] The present invention does not require high-cost sequencing of ATAC-seq or ChIP-seq of a large sample population. Only the genotype of the population and the ATAC-seq or ChIP-seq data of a single sample are needed to obtain the regulatory element activity of all individuals in the population. The cost required for sequencing in traditional schemes is greatly reduced. The present invention can make full use of the large amount of eQTL data currently available and the ATAC-seq or ChIP-seq data in public databases. There is no need to re-sequence these samples, and the regulatory element activity and target genes of a large number of tissues can be directly detected, which greatly saves the time and economic cost required for sample collection. The present invention combines the regulatory role of genomic regulatory elements and susceptible variants in a variety of diseases. This method can be used to systematically identify the functions of genomic regulatory elements and susceptible variants of complex human diseases, and is widely used in basic research, providing a theoretical basis for genetic mechanism research and drug development of related diseases in the future biomedical field. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the embodiments of the present invention or the drawings of related technical solutions in the prior art are introduced below. It should be understood that the drawings introduced below are only for the convenience of clearly describing some embodiments of the technical solutions of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative work.

[0037] Figure 1 This is a flow chart of the method for identifying functional chromatin regulatory regions and target genes of the present invention;

[0038] Figure 2This is a schematic diagram of the functional chromatin regulatory region and target gene identification principle of the present invention;

[0039] Figure 3 This is a diagram showing the results of third-party independent data verification of the functional chromatin regulatory region and target gene identification of the present invention;

[0040] Figure 4 The present invention provides a functional chromatin regulatory region and target gene identification system. DETAILED DESCRIPTION

[0041] The embodiments of the present invention are described in detail below, and examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain the present invention, and are not to be construed as limitations of the present invention. For the step numbers in the following embodiments, they are only provided for the convenience of explanation, and the order between the steps is not limited in any way, and the execution order of each step in the embodiment can be adaptively adjusted according to the understanding of those skilled in the art.

[0042] In the description of the present invention, unless otherwise clearly defined, terms such as setting, installing, connecting, etc. should be understood in a broad sense, and technicians in the relevant technical field can reasonably determine the specific meanings of the above terms in the present invention based on the specific content of the technical solution.

[0043] The present invention has developed a new method, which, based on the original eQTL data, only requires ATAC-seq data of a small number of samples or ChIP-seq data of histones / transcription factors, to calculate the relationship between regulatory element activity and gene expression at the population level, thereby identifying functional regulatory elements and their target genes.

[0044] The present invention relates to the field of biotechnology, and more particularly to a method for identifying functional chromatin regulatory regions and target genes at the population level, and more particularly to predicting chromatin states using population genomes, thereby identifying genomic regulatory elements that regulate gene expression at the population level. This method can be used to systematically explore the functions of genomic regulatory elements and the target genes they affect.

[0045] The present invention is used to systematically explore the functions of genomic regulatory elements and the target genes they affect, providing a theoretical basis and potential targets for the screening of molecular genetic markers for complex human diseases and subsequent treatment, thus bringing certain economic benefits.

[0046] This invention studies a method for identifying functional chromatin regulatory regions and target genes at the population level. Combined with the regulatory role of genomic regulatory elements and susceptibility variants in various diseases, this method can be used to systematically identify the functions of genomic regulatory elements and susceptibility variants in complex human diseases, which can be widely used in basic research and provide a theoretical basis for genetic mechanism research and drug development of related diseases in the future biomedical field.

[0047] For this reason, Figure 1 As shown, the present invention provides a method for identifying a functional chromatin regulatory region and a target gene, comprising the following steps:

[0048] S1, screening regulatory element regions on the genome; using the trained gapped-kmer SVM model to predict activity scores for the 9bp sequences upstream and downstream of the two alleles of all SNPs in all regulatory element regions;

[0049] S2, for each individual in the eQTL population, the activities of all PREs were calculated based on the activity score of each allele type according to the genotype information of each SNP;

[0050] S3, for each gene, use the linear regression model to calculate the association between the gene and the activity of all PREs in the preset range of upstream and downstream of its promoter, calculate the effect value β of the linear regression, and then obtain the significant P value;

[0051] S4, multiple testing correction is performed based on the total number of significant P-value tests, and statistically significant results are screened out as the final regulatory element-target gene regulation results.

[0052] The present invention uses epigenetic data (such as ATAC-seq, ChIP-seq, etc.) of a small number of individuals to model the genotype, thereby predicting the activity scores of different alleles of SNPs on individual regulatory elements in a large sample population. The activity scores of different alleles of SNPs on the predicted regulatory elements are used as weights, and the SNPs on the regulatory elements are weighted and summed to obtain the predicted regulatory element activity through the gene dosage effect. The changes in the predicted regulatory element activity in the large sample population are used to perform association analysis with population phenotypes such as gene expression.

[0053] The present invention aims to identify functional chromatin regulatory regions and target genes at the population level through a series of steps. The core is to use epigenetic data of a small number of individuals to model genotypes, and then predict and analyze them in a large sample population to determine the relationship between regulatory elements and target genes, providing a theoretical basis and potential targets for the study of complex human diseases.

[0054] Screening regulatory element regions on the genome (S1): Use the trained gapped-kmer SVM model to predict the activity scores of the 9bp sequences upstream and downstream of the two alleles of all SNPs in all regulatory element regions. The principle of this step is to analyze the sequences around the SNPs through a specific model to evaluate the potential activity of different alleles. SNP (single nucleotide polymorphism) is the most common form of variation in the genome, and its different alleles may affect the activity of regulatory elements. By predicting these sequences, basic data can be provided for subsequent analysis.

[0055] Calculate individual PRE activity (S2): For each individual in the eQTL population, the activity of all PREs (possible regulatory elements) is calculated based on the genotype information of each SNP and the activity score of each allele. The principle of this step is to calculate the activity of each possible regulatory element in the individual based on the individual's genotype information and the previously predicted allele activity score. By considering the genotypes of different SNPs, the activity changes of regulatory elements in the population can be more accurately evaluated.

[0056] Association analysis (S3): For each gene, a linear regression model is used to calculate the association between the gene and all PRE activities within a preset range (e.g., within 1MB) upstream and downstream of its promoter, and the effect value β of the linear regression is calculated to obtain a significant P value. The principle of this step is to analyze the relationship between the gene and the activity of the regulatory element through a linear regression model. Linear regression can evaluate the strength of the linear relationship between two variables. Here, the population phenotype such as gene expression is used as the dependent variable, and the activity of the regulatory element is used as the independent variable. By calculating the effect value β and the significant P value, it can be determined whether the effect of the regulatory element on gene expression is statistically significant.

[0057] Multiple test correction (S4): Multiple test correction is performed based on the total number of significant P value tests to screen out statistically significant results as the final regulatory element-target gene regulation results. The principle of this step is that multiple tests are performed in large-scale data analysis, which may lead to an increase in false positive results. Therefore, multiple test correction is required to control the false discovery rate. By screening out statistically significant results, the reliability and accuracy of the results can be improved.

[0058] Based on epigenetic data, the present invention identifies functional chromatin regulatory regions and target genes at the population level through modeling and analysis of genotypes. This method can systematically explore the functions of genomic regulatory elements and the target genes they affect, providing a theoretical basis and potential targets for molecular genetic marker screening and subsequent treatment of complex human diseases. At the same time, this method also provides an important theoretical basis for the study of genetic mechanisms and drug development of related diseases in the biomedical field.

[0059] The present invention will be further described in detail below with reference to the accompanying drawings and specific embodiments.

[0060] Therefore, in order to solve this problem, the present invention has developed a new method, which, based on the original eQTL data, only requires ATAC-seq data of a small number of samples or ChIP-seq data of histones / transcription factors, to calculate the relationship between regulatory element activity and gene expression at the population level, thereby identifying functional regulatory elements and their target genes.

[0061] refer to Figure 1 It is used to specifically demonstrate the working principle of the method of the present invention:

[0062] Step 1 The model training process is as follows:

[0063] a. Sequences within 100bp upstream and downstream of the peak point in the peak area of ​​ATAC-seq / ChIP-seq were selected as the positive set, and the same number of sequences in the non-peak area of ​​ATAC-seq / ChIP-seq (the area with peak call P value>0.2) were randomly selected as the negative set, and the length, repetition rate, and GC content of the randomly obtained negative set sequences were guaranteed to be the same as those in the positive set.

[0064] b. Use the negative set and positive set sequences as training sets, train the gapped-kmer SVM (support vector machine) model in a 5-fold crossover method, search for the optimal hyperparameters, and take the model with the highest area under the precision-recall curve (AUPRC) of the validation set as the model for subsequent use.

[0065] Step 2 The mutation site prediction scoring process is as follows

[0066] a. Screen regulatory element regions. All ATAC-seq / ChIP-seq peak regions on the genome are used as candidate regulatory element regions (Potential Regulatory Elements, PREs), and the following PRE regions are filtered out:

[0067] a) There are base insertion and deletion mutations in the PRE region.

[0068] b) The number of independent SNPs in the region within the PRE is less than 2, and the independence threshold is linkage disequilibrium R2>0.3.

[0069] c) There are two SNPs within the PRE with a distance <10 bp between them.

[0070] b. Use the gapped-kmer SVM model trained in the previous step to predict the activity score of the 9bp sequence upstream and downstream (19bp in total) of the two alleles of all SNPs in all PRE regions.

[0071] Step 3: quantification of regulatory element activity is as follows

[0072] For each individual in the eQTL population, the activity of all PREs was calculated based on the activity score of each allele according to the genotype information of each SNP, and the calculation method was:

[0073]

[0074] where CAS is the PRE activity, n is the number of SNPs in the PRE region, m is the number of alleles of SNP i, G is the dosage effect of allele j, and S is the score of allele j predicted by the gapped-kmer SVM model.

[0075] Step 4: Calculate the correlation between regulatory element activity and gene expression as follows

[0076] For each gene, a linear regression model was used to calculate the association between the gene and all PRE activities within 1MB upstream and downstream of its promoter, and the effect value β of the linear regression and its significant P value were calculated:

[0077] eXpres81011~0×AS+Covariates

[0078] Expression is the normalized expression value of the gene, CAS is the activity of the PRE, Covariates is the population covariate, and β is the effect value of the PRE on gene expression. Finally, multiple test correction (FDR method) was performed based on the total number of significant P value tests to screen out statistically significant results as the final regulatory element-target gene regulation results.

[0079] The present invention is not limited to detecting the activity of regulatory elements and target genes, and can be easily expanded. By expanding gene expression to more molecular phenotypes, such as protein expression, and even individual phenotypes, the existing QTL data and GWAS data can be fully utilized to more extensively study the functions of genomic regulatory elements.

[0080] As reference Figure 3 As shown, the present invention is verified by a third-party independent data set, which, in addition to the data types required by the present method, also has directly sequenced population chromatin accessibility data, so the chromatin regulatory element regions associated with gene expression can be directly calculated. After verification, the AUC of the method of the present invention is 0.81, indicating that the calculation results of the present invention are good and reliable.

[0081] like Figure 4 As shown, the second object of the present invention is to provide a functional chromatin regulatory region and target gene identification system, comprising:

[0082] The activity score prediction module is used to screen the regulatory element regions on the genome; the trained gapped-kmerSVM model is used to predict the activity scores of the 9bp sequences upstream and downstream of the two allele types of all SNPs in all regulatory element regions;

[0083] The activity calculation module is used to calculate the activity of all PREs according to the activity score of each allele type for each individual in the eQTL population based on the genotype information of each SNP;

[0084] The significant P value calculation module is used to calculate the association between each gene and all PRE activities within the preset range of the upstream and downstream of its promoter using a linear regression model, calculate the effect value β of the linear regression, and then obtain the significant P value;

[0085] The result screening module is used to perform multiple test correction according to the total number of detections of significant P values, and screen out statistically significant results as the final regulatory element-target gene regulation results.

[0086] The system is based on the above-mentioned functional chromatin regulatory region and target gene identification method.

[0087] The third object of the embodiment of the present invention is to provide an electronic device, comprising a memory, a processor, and a computer program stored in the memory and executable on the processor, wherein the processor implements the functional chromatin regulatory region and target gene identification method when executing the computer program. It also includes a communication interface and a bus.

[0088] A fourth object of an embodiment of the present invention is to provide a computer-readable storage medium, wherein the computer-readable storage medium stores a computer program, and when the computer program is executed by a processor, the functional chromatin regulatory region and target gene identification method is implemented.

[0089] A fifth object of an embodiment of the present invention is to provide a computer program product, which includes computer instructions, characterized in that the computer instructions instruct a computer to execute the method for identifying functional chromatin regulatory regions and target genes.

[0090] These computer program instructions may also be stored in a computer-readable memory capable of directing a computer or other programmable data processing device to operate in a specific manner, so that the instructions stored in the computer-readable memory produce an article of manufacture comprising an instruction device, which implements the process Figure 1 A process or multiple processes and / or boxes Figure 1 A function specified in one or more boxes.

[0091] These computer program instructions can also be loaded onto a computer or other programmable data processing device so that a series of operating steps are executed on the computer or other programmable device to produce a computer-implemented process, thereby providing instructions for implementing the process. Figure 1 A process or multiple processes and / or boxes Figure 1 The steps for the functions specified in one or more boxes.

[0092] The present invention may take the form of a complete hardware embodiment, a complete software embodiment, or an embodiment combining software and hardware. Moreover, the present invention may take the form of a computer program product implemented on one or more computer-usable storage media (including but not limited to disk storage, readable storage media, optical storage, etc.) containing computer-usable program codes.

[0093] The present invention is described with reference to flowcharts and / or block diagrams of methods, devices (systems), and computer program products according to embodiments of the present invention. It should be understood that each process and / or block in the flowchart and / or block diagram, as well as the combination of processes and / or blocks in the flowchart and / or block diagram, can be implemented by computer program instructions. These computer program instructions can be provided to a processor of a general-purpose computer, a special-purpose computer, an embedded processor, or other programmable data processing device to produce a machine, so that the instructions executed by the processor of the computer or other programmable data processing device generate instructions for implementing the processes in the flowchart and / or block diagram. Figure 1 A process or multiple processes and / or boxes Figure 1 A device that provides the functions specified in a block or multiple blocks.

[0094] Obviously, the described embodiments are only some embodiments of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.

[0095] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the above embodiments, ordinary technicians in the relevant field should understand that the specific implementation methods of the present invention can still be modified or replaced by equivalents. Any modification or equivalent replacement that does not depart from the spirit and scope of the present invention should be covered within the scope of protection of the claims of the present invention.

Claims

1. A method for identifying functional chromatin regulatory regions and target genes, characterized in that: include: Screening regulatory element regions on the genome; The trained gapped-kmer SVM model was used to predict the activity scores of the 9 bp sequences upstream and downstream of the two alleles of all SNPs in all regulatory element regions; For each individual in the eQTL population, the activities of all PREs were calculated based on the activity score of each allele type according to the genotype information of each SNP; For each gene, a linear regression model was used to calculate the association between the gene and all PRE activities within a preset range upstream and downstream of its promoter, and the effect value β of the linear regression was calculated to obtain a significant P value. Multiple testing correction was performed based on the total number of significant P-value tests, and statistically significant results were screened out as the final regulatory element-target gene regulation results.

2. A method for identifying a functional chromatin regulatory region and a target gene according to claim 1, characterized in that: The screening of regulatory element regions on the genome comprises: All ATAC-seq / ChIP-seq peak regions on the genome were used as candidate regulatory element regions, and the following PRE regions were filtered out: a) There are base insertion and deletion mutations in the PRE region; b) The number of independent SNPs in the region within the PRE is less than 2, and the independence threshold is linkage disequilibrium R2>0.3; c) There are two SNPs within the PRE with a distance <10 bp between them.

3. A method for identifying a functional chromatin regulatory region and a target gene according to claim 1, characterized in that: The training process of the gapped-kmer SVM model includes: The sequences within 100 bp upstream and downstream of the peak point in the ATAC-seq / ChIP-seq peak area were taken as the positive set, and the same number of sequences in the non-peak area of ​​ATAC-seq / ChIP-seq were randomly taken as the negative set; The negative set and positive set sequences were used as training sets, and the gapped-kmer SVM model was trained in a 5-fold crossover method to search for the optimal hyperparameters. The model with the highest surface under the precision-recall curve of the validation set was taken as the trained gapped-kmer SVM model.

4. A method for identifying a functional chromatin regulatory region and a target gene according to claim 3, characterized in that: The non-peak region sequence is a region with a calling peak P value>0.2, and the length, repetition rate, and GC content of the negative set sequence randomly obtained in the negative set are the same as those of the positive set.

5. A method for identifying a functional chromatin regulatory region and a target gene according to claim 1, characterized in that: The activity of all PREs is calculated based on the activity score of each allele type, and the calculation method is: where CAS is the PRE activity, n is the number of SNPs in the PRE region, m is the number of alleles of SNP i, G is the dosage effect of allele j, and S is the score of allele j predicted by the gapped-kmer SVM model.

6. A method for identifying a functional chromatin regulatory region and a target gene according to claim 1, characterized in that: The linear regression model is: expression~β1×CAS+Covariates Among them, expression is the expression value of the gene after standardization, CAS is the activity of the PRE, Covariates is the population covariate, and β is the effect value of the PRE on gene expression.

7. A functional chromatin regulatory region and target gene identification system, characterized in that: include: The activity score prediction module is used to screen the regulatory element regions on the genome; the trained gapped-kmer SVM model is used to predict the activity scores of the 9bp sequences upstream and downstream of the two alleles of all SNPs in all regulatory element regions; The activity calculation module is used to calculate the activity of all PREs according to the activity score of each allele type for each individual in the eQTL population based on the genotype information of each SNP; The significant P value calculation module is used to calculate the association between each gene and all PRE activities within the preset range of the upstream and downstream of its promoter using a linear regression model, calculate the effect value β of the linear regression, and then obtain the significant P value; The result screening module is used to perform multiple test correction according to the total number of detections of significant P values, and screen out statistically significant results as the final regulatory element-target gene regulation results.

8. An electronic device, characterized in that: The invention comprises a memory, a processor and a computer program stored in the memory and executable on the processor, wherein when the processor executes the computer program, the method for identifying a functional chromatin regulatory region and a target gene according to any one of claims 1 to 6 is implemented.

9. A computer-readable storage medium, characterized in that: The computer-readable storage medium stores a computer program, and when the computer program is executed by a processor, the method for identifying a functional chromatin regulatory region and a target gene according to any one of claims 1 to 6 is implemented.

10. A computer program product, comprising computer instructions, characterized in that: The computer instructions instruct the computer to execute the method for identifying functional chromatin regulatory regions and target genes according to any one of claims 1 to 6.

Citation Information

Cited By

  • Screening method of susceptible SNP site target gene for AML diagnosis and application thereof

    CN119580833A